Re-appointment of M/s. Jaymin Shah & Associates, Chartered Accountants (FRN No. 129406W) as the Statutory Auditor of the Company for the Financial Year 2025-26.

pdf

Ishita Drugs & Industries Ltd.

01 Oct 2025

73.17

-0.68%

Company Update

Ishita Drugs & Industries Ltd - 524400 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

1. Approval of Re-appointment of Mr. Arvind Vilasrao Sapkal[DIN: 08607096] as a non-executive independent director of the company for his second term of 5 (Five) years. 2. Approval of Appointment of M/s Meenu Maheshwari & Associates , Company Secretary in Practice, as Secretarial Auditor of the Company for a term of 5 (Five) years. 3. Approval of Appointment of M/s. Jaymin Shah & Associates, Chaetered Accountants, as the Statutory Auditor of the Company for the FY 2025-26.

pdf

Ishita Drugs & Industries Ltd.

01 Oct 2025

73.17

-0.68%

AGM

Ishita Drugs & Industries Ltd - 524400 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Disclosure of Voting Results and Scrutinizer''s Report for 32nd Annual General Meeting of the Company held on Monday, 29th September, 2025

pdf

Ishita Drugs & Industries Ltd.

29 Sep 2025

73.17

-0.68%

AGM

Ishita Drugs & Industries Ltd - 524400 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Proceedings of 32nd Annual General Meeting of the Company held on Monday, 29th September, 2025 at 11:30 A.M. and concluded on 12:40 P.M.

pdf

Ishita Drugs & Industries Ltd.

25 Sep 2025

73.17

-0.68%

SAST

Ishita Drugs & Industries Ltd - 524400 - Closure of Trading Window

BSE India

The trading window for dealing in securities of the Company by designated persons stand closed from Wednesday, 01st October, 2025 till 48 hours after the declaration of Unaudited Financial Results for the quarter ended 30th September, 2025.

pdf

Ishita Drugs & Industries Ltd.

17 Sep 2025, 05:37PM

73.17

-0.68%

Company Update

Ishita Drugs & Industries Ltd - 524400 - Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition …

BSE India

Disclosure under Regulation 29(2) of SEBI(SAST) Regulations, 2011 received from Ishita Pharmaceuticals, related party of Ishita Drugs and Industries Limited.

pdf

Ishita Drugs & Industries Ltd.

05 Sep 2025

73.17

-0.68%

Company Update

Ishita Drugs & Industries Ltd - 524400 - Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition …

BSE India

Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 received from Jagdish Agrawal

pdf

Ishita Drugs & Industries Ltd.

05 Sep 2025

73.17

-0.68%

Company Update

Ishita Drugs & Industries Ltd - 524400 - Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition …

BSE India

Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 received from Jagdish Agrawal

pdf

Ishita Drugs & Industries Ltd.

02 Sep 2025

73.17

-0.68%

Corp. Note

Ishita Drugs & Industries Ltd - 524400 - Reg. 34 (1) Annual Report.

BSE India

Pursuant to the provisions of Regulation 34 of the SEBI (LODR) Regulations, 2015 we are enclosing herewith Annual Report for the Financial Year 2024-25 along with the Notice of 32nd Annual General Meeting (AGM) of the Company to be held on Monday, 29th September, 2025.

pdf

Is Ishita Drugs & Industries Ltd. worth buying?

11 Votes:

Buy 81.82%

Sell 9.09%

Hold 9.09%